Rhinocerebral Mucormycosis with Orosinusal Involvement: Diagnostic and Surgical Treatment Guidelines

Author(s): Giuseppe Giudice, Daniela Anna Cutrignelli, Pasquale Sportelli, Luisa Limongelli, Angela Tempesta, Giuseppe Di Gioia, Luigi Santacroce, Eugenio Maiorano, Gianfranco Favia

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 16 , Issue 4 , 2016

Become EABM
Become Reviewer
Call for Editor


Background: Rhinocerebral mucormycosis is a rare, rapidly progressive and potentially lethal disease almost exclusively affecting immunocompromised hosts or patients with metabolic disorders, such as poorly controlled diabetes mellitus.

Methods: This work is aimed to describe five cases of rhinocerebral mucormycosis to review and possibly define diagnostic and surgical treatment guidelines. In all the patients, surgical debridement, systemic and local antifungal therapy, and oral rehabilitation using filling prostheses were performed.

Results: None of the patients revealed recurrence of the infection, as confirmed by radiological and clinical long term follow up.

Conclusion: Given the lethal nature of the disease, the authors underline the importance of early diagnosis and of a multidisciplinary approach in order to undertake correct surgical and medical treatments, while keeping the underlying disease under control.

Keywords: Zygomycetes, Mucorales, rhinocerebral mucormycosis, immunocompromised patients, sinusitis, surgical debridement.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 08 February, 2017
Page: [264 - 269]
Pages: 6
DOI: 10.2174/1871530316666161223145055
Price: $65

Article Metrics

PDF: 26